Fig. 7From: An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancersPrediction of drug sensitivity in distinct EMTG risk score groups of OC. A-H Scatter and box plots showing the correlations of EMTG risk score with IC50 of XAV-939 (A), Bleomycin (B), Staurosporine (C), AT-9283 (D), Lapatinib (E), Nilotinib (F), Luminespib (G), and Volasertib (H)Back to article page